Experimental Gene Therapy Successful In Certain Lymphomas And Leukemia

Study results of CD19-directed chimeric antigen receptor (CAR) therapy using the Sleeping Beauty non-viral transduction system to modify T cells has demonstrated further promise in patients with advanced hematologic malignancies.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news